Gartner Recognizes Infinx as Sample Vendor for Intelligent Prior Authorization in Hype Cycle for US Healthcare Payers 2024 for Third Consecutive Year

August 27, 2024 8:00 AM

CUPERTINO, CA / ACCESSWIRE / August 27, 2024 / Infinx Healthcare, a leading provider of AI-driven patient access and revenue cycle solutions for healthcare providers, has been recognized as a Sample Vendor for a third year in a row for Intelligent Prior Authorization in the Gartner Hype Cycle for US Healthcare Payers in 2024.Gartner Hype Cycle methodology gives a view of how a technology or application will evolve over time, providing a sound...

Read more

CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries

August 27, 2024 8:00 AM

The targeted acquisitions are estimated to have a business value of approximately $14 millionSCOTTSDALE, AZ / ACCESSWIRE / August 27, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leading innovator in the CBD industry, is pleased to announce that the company is in advanced discussions to acquire a strategic minority interest in two state-licensed cannabis dispensaries located in Upstate New York and Long Island. This acquisition...

Read more

Compassion Center and CIFR Honored to Present at the VA/DOD Suicide Prevention Conference 2024, Increasing the Reach and Improving Outcomes for Veterans and Active Duty Military

August 27, 2024 8:00 AM

HILLSBORO, OR / ACCESSWIRE / August 27, 2024 / Compassion Center, in collaboration with the Institute for Suicide & Homicide Prevention (ISHP) and CIFR, presented groundbreaking sessions on integrative healthcare and mental health at the 2024 VA/DoD Suicide Prevention Conference. Their participation highlighted innovative approaches to suicide and homicide prevention, fostering dialogue among global experts. The event culminated in a hospitality...

Read more

Avant Brands Announces 30:1 Share Consolidation

August 27, 2024 7:30 AM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, announces that it will consolidate its outstanding common shares on the basis of thirty (30) existing common shares for one (1) new common share of the Company (the "Consolidation"). In accordance with the articles of the Company, the Consolidation has been approved by the board of directors (the...

Read more

InStride Health, a Specialty Pediatric Anxiety/OCD Outpatient Treatment Provider, Expands Access for Youth in Ohio

August 27, 2024 7:00 AM

CLEVELAND, OH / ACCESSWIRE / August 27, 2024 / InStride Health, an outpatient provider of specialty pediatric anxiety and OCD care, is expanding services into Ohio and is in-network with Anthem BCBS, Optum, UnitedHealthcare, Oscar, Oxford Health Plan, and Government Employees Health Association (GEHA). InStride Health Logo In response to the growing pediatric mental health crisis across the United States and the lack of immediate and...

Read more

InStride Health, a Specialty Provider of Pediatric Anxiety/OCD Outpatient Treatment, Expands Access for Youth in Virginia

August 27, 2024 7:00 AM

RICHMOND, VA / ACCESSWIRE / August 27, 2024 / InStride Health, an outpatient provider of specialty pediatric anxiety and OCD care, is expanding services into Virginia and is in-network with Anthem BCBS, Optum, UnitedHealthcare, Oscar, Oxford Health Plan, and Government Employees Health Association (GEHA). InStride Health Logo In response to the growing pediatric mental health crisis across the United States and the lack of immediate and...

Read more

Cantargia Reports Timelines for Nadunolimab Clinical Trials in Leukemia and Triple Negative Breast Cancer

August 27, 2024 5:00 AM

LUND, SE / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported currently expected timelines for nadunolimab clinical trials. The US FDA has granted MD Andersson Cancer Center the IND for nadunolimab related to the upcoming phase 1b/2a clinical trial of patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an estimate for trial initiation during Q4 2024....

Read more

Spago Nanomedical's Phase I/IIa Study Tumorad-01 Continues Following Successful Treatment Completion of First Patient Group

August 27, 2024 4:00 AM

LUND, SE / ACCESSWIRE / August 27, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today announced that the independent Data Monitoring Committee (DMC) recommends to proceed the clinical phase I/IIa study Tumorad-01 with the candidate drug 177Lu-SN201, with inclusion of patients with different tumor types. The recommendation is based on an analysis of data from the first three treated patients in the study that the...

Read more

Steraloids Teams Up With Bioz to Deliver Advanced Research Tools and Insights Through AI-Powered Badges

August 27, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / August 27, 2024 / Bioz, Inc. a leader in AI-powered research solutions, is excited to announce a new strategic partnership with Steraloids, a premier provider of high-quality steroid and hormone products for research applications. This collaboration is set to redefine how researchers access and evaluate Steraloids' offerings, thanks to Bioz's groundbreaking technology.Bioz Prime Badge Bioz Prime Badge on the...

Read more

Minerva Surgical Launches Next Generation Symphion Fluid Management Accessory with Fluid Deficit Readout

August 26, 2024 2:00 PM

Minerva Surgical, a manufacturer and distributor of minimally invasive gynecologic surgical technologies, today announced the launch of the Symphion Fluid Deficit Readout, an optional accessory that provides fluid deficit volume readings during operative hysteroscopy procedures.Operative hysteroscopy is a surgical procedure that requires precise fluid management to prevent complications. The Symphion Fluid Deficit Readout, which is intended for...

Read more

AllStar Health Brands / AllStar Global Brands Sign Enzo Concina Pro Scout and Senior Italian Consultant

August 26, 2024 1:00 PM

AllStar is excited to announce the signing of Enzo Concina, whose resume speaks for itself. A senior scout for a top Serie A team and previous professional soccer player for Montreal Impact and also Piacenza, Serie B.Enzo's duty is for pro scouting for North America and Europe and also for soccer affiliation with a top professional team in Serie C. Enzo's experience is both in Italy and also North America, where he played professionally. We here...

Read more

Healthcare Navigation Service Doctor Global Launches an Extensive Database of Clinics Worldwide

August 26, 2024 12:15 PM

Doctor Global, a healthcare navigation service, has launched an extensive database of clinics worldwide. The platform provides patients with a comprehensive tool to find medical services across various regions and specialties. The newly launched database includes thousands of clinics and offers a wide range of options for patients seeking medical care outside their home country. The platform allows patients to search for clinics using various...

Read more

100 New Moms Celebrated at Community Baby Shower Hosted by Q4HE Grantee

August 26, 2024 9:30 AM

NORTHAMPTON, MA / ACCESSWIRE / August 26, 2024 / Quest Diagnostics Bread of Life, Inc., a Quest for Health Equity (Q4HE) grantee, recently hosted its third annual Community Baby Shower in Houston, where 100 expectant moms and their guests were showered with refreshments, games, entertainment-and plenty of baby gear.Guests received giveaway prizes of car seats, diaper bags, high chairs, playpens, and more, and had the opportunity to stock up on...

Read more

GetHealthy.store Launching "NIKKI"

August 26, 2024 9:00 AM

Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited to announce that its wholly-owned subsidiary, FREmedica Technologies Inc. ("FREmedica"), is partnering with GetHealthy.store to launch "NIKKI," a personal frequency delivery system you wear. This is the first of 3 agreements to be signed.The first agreement grants FREmedica exclusive access to launch NIKKI to the GetHeathy.store Catalogue which currently...

Read more

KindlyMD to Participate in H.C. Wainwright’s 26th Annual Global Investment Conference on September 9-11, 2024

August 26, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that KindlyMD CEO, Tim Pickett, will participate in H.C. Wainwright's 26th Annual Global Investment Conference being held at the Lotte New York Palace Hotel in New York City on...

Read more

Beyond Medals: The Toughest Discipline is Overcoming Daily Disability Barriers

August 26, 2024 9:00 AM

Ottobock Launches Paralympic Games Initiative: ‘The Unofficial Discipline'BURLINGTON, ON / ACCESSWIRE / August 26, 2024 / As the world gathers in Paris for the Paralympic Games and athletes compete across 23 disciplines, Ottobock, with the support of the International Paralympic Committee (IPC), is launching a symbolic new discipline. In this ‘Unofficial Discipline,' people with disabilities face involuntary challenges every day. It's about...

Read more

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

August 26, 2024 8:30 AM

SAN DIEGO, CA / ACCESSWIRE / August 26, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, is pleased to provide an update letter to shareholders from its Chairman of the Board, President, and Chief Executive Officer, Mr. Chun-Hsien (Eddy) Tsai.Dear Shareholders,Since rebranding to...

Read more

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

August 26, 2024 8:30 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, and its partner, the MicroSafe Group DMCC, announce that the Australian Therapeutic Goods Administration (TGA) has approved...

Read more

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

August 26, 2024 8:00 AM

FORT LAUDERDALE, FL / ACCESSWIRE / August 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has launched nine (9) new generic prescription drugs year-to-date. These launches bring the total number of drugs that the Company has on the market in Canada to sixty-one...

Read more

MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study

August 26, 2024 8:00 AM

Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIAMI, FL / ACCESSWIRE / August 26, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is proud to announce a major breakthrough in the treatment of neuropathic pain. A recent pre-clinical study in rats demonstrated that its novel oral ketamine analog, Ketamir-2,...

Read more